Related Experiment Video
Updated: Jan 7, 2026

Pulse Wave Velocity Testing in the Baltimore Longitudinal Study of Aging
Published on: February 7, 2014
HIV and ART status at baseline are associated longitudinally with increased pulse wave velocity: findings from the
Patane S Shilabye1,2, Karine Scheuermaier2, Chijioke N Umunnakwe3
1Julius Global Health, Department of Global Public Health and Bioethics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Insights
People living with HIV (PLWH) experience increased arterial stiffness (PWV) over time, especially after starting antiretroviral therapy (ART). Early cardiovascular disease (CVD) risk monitoring is crucial for PLWH in resource-limited settings.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- People living with HIV (PLWH) face a higher risk of cardiovascular disease (CVD).
- Longitudinal data on CVD risk markers in PLWH from middle-income countries are limited.
- Pulse wave velocity (PWV) is a key indicator of arterial stiffness and CVD risk.
Purpose of the Study:
- To investigate the association between HIV, antiretroviral therapy (ART), and PWV.
- To analyze longitudinal changes in PWV among PLWH and HIV-negative individuals.
- To assess CVD risk progression in a South African cohort.
Main Methods:
- Longitudinal analysis of the Ndlovu Cohort Study in South Africa.
- Inclusion of 705 participants: 325 PLWH and 380 HIV-negative individuals.
- Mixed-effects models used to analyze PWV changes over 36 months, adjusting for covariates.
Main Results:
- PWV increased significantly over 36 months in both PLWH (0.30 m/s) and HIV-negative individuals (0.20 m/s).
- PLWH exhibited higher median PWV at 12 months (7.3 m/s) compared to HIV-negative peers (7.0 m/s).
- Individuals initiating ART showed the most substantial PWV increase, particularly between 12 and 36 months.
Conclusions:
- Arterial stiffness (PWV) progresses over time, with a more pronounced increase observed in PLWH.
- Antiretroviral therapy (ART) initiation is associated with rapid increases in PWV.
- Emphasizes the need for early cardiovascular disease risk monitoring in PLWH, especially after ART initiation, in resource-limited settings.
Objectives:
People with HIV (PWH) have an increased risk of cardiovascular disease (CVD), but longitudinal data from middle-income settings remain limited. This study examined the association between HIV, antiretroviral therapy (ART), and pulse wave velocity (PWV), a marker of arterial stiffness and CVD risk.
Design:
A longitudinal analysis from the Ndlovu Cohort Study, South Africa.
Methods:
The study included 705 participants (325 PWH, 81% on ART at baseline, 19% initiating ART at baseline, and 380 HIV-negative people. Demographic data, HIV/ART status, and covariates were collected at baseline, while PWV was measured at 12 and 36 months. Mixed-effects models were used to analyze PWV changes over time, adjusting for age, sex, and systolic blood pressure (SBP). Results were reported as beta coefficients ( β ) with 95% confidence intervals (CIs).
Results:
At baseline, PWH were older and predominantly female (67%) compared to HIV-negative people. At 12 months, median PWV was higher in PWH (7.3 m/s) than in HIV-negative people (7.0 m/s, P = 0.001). Over 36 months, PWV increased by 0.30 m/s in PWH and 0.20 m/s in HIV-negative people ( P = 0.002). ART-naïve individuals had the largest PWV increase after starting ART (6.8 m/s at 12 months to 7.4 m/s at 36 months, P = 0.001). HIV ( β = 0.65, 95% CI: 0.24-1.06, P = 0.002) and time ( β = 0.31 m/s per year, P < 0.001) were significantly associated with higher PWV.
Conclusions:
PWV increased over time, particularly in PWH, with ART initiation linked to rapid increases. These findings highlight the need for early CVD risk monitoring, especially post-ART initiation, in resource-limited settings.
More Related Videos
13:58Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
Published on: September 26, 2011
09:54Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
Published on: December 3, 2019
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Assessing Blood pressure using a doppler ultrasound
Pre-Procedural Guidelines for Doppler Ultrasound Blood Pressure Assessment:
Preparation of Equipment:
Longitudinal Studies
Hypertension III: Clinical Manifestations and Diagnostic Studies
Pulse Assessment Sites